$127.20
1.61% yesterday
NYSE, Dec 08, 10:13 pm CET
ISIN
US0126531013
Symbol
ALB
Sector
Industry

Albemarle Stock price

$127.20
+23.62 22.80% 1M
+64.90 104.17% 6M
+41.12 47.77% YTD
+17.54 15.99% 1Y
-128.83 50.32% 3Y
-16.75 11.64% 5Y
+77.42 155.52% 10Y
+108.38 575.88% 20Y
NYSE, Closing price Mon, Dec 08 2025
+2.01 1.61%
ISIN
US0126531013
Symbol
ALB
Sector
Industry

New AI Insights on Albemarle Insights AI Insights on Albemarle

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$15.0b
Enterprise Value
$16.7b
Net debt
$1.7b
Cash
$1.9b
Shares outstanding
117.7m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
3.0 | 3.0
EV/Sales
3.4 | 3.3
EV/FCF
159.8
P/B
1.5
Dividends
DPS
$1.62
Yield 1Y | 5Y
1.3% | 1.0%
Growth 1Y | 5Y
0.6% | 1.0%
Payout 1Y | 3Y
-14.4% | 19.2%
Increased
25 Years
Financials (TTM | estimate)
Revenue
$4.9b | $5.0b
EBITDA
$678.4m | $998.7m
EBIT
$20.3m | $-37.2m
Net Income
$-187.9m | $-112.5m
Free Cash Flow
$104.3m
Growth (TTM | estimate)
Revenue
-23.9% | -6.3%
EBITDA
193.6% | 2,555.6%
EBIT
101.6% | 94.1%
Net Income
90.4% | 91.5%
Free Cash Flow
107.4%
Margin (TTM | estimate)
Gross
12.3%
EBITDA
13.7% | 19.8%
EBIT
0.4%
Net
-3.8% | -2.2%
Free Cash Flow
2.1%
Financial Health
Equity Ratio
60.0%
Return on Equity
-13.2%
ROCE
0.1%
ROIC
0.2%
Debt/Equity
0.4
More
EPS
$-1.6
FCF per Share
$0.9
Short interest
13.9%
Employees
8k
Rev per Employee
$650.0k
Show more

Is Albemarle a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,088 stocks worldwide.

Albemarle Stock Analysis

Unlock Scores for Free

Analyst Opinions

31 Analysts have issued a Albemarle forecast:

11x Buy
35%
17x Hold
55%
3x Sell
10%

Analyst Opinions

31 Analysts have issued a Albemarle forecast:

Buy
35%
Hold
55%
Sell
10%

Financial data from Albemarle

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
4,946 4,946
24% 24%
100%
- Direct Costs 4,337 4,337
40% 40%
88%
609 609
179% 179%
12%
- Selling and Administrative Expenses 529 529
21% 21%
11%
- Research and Development Expense 59 59
34% 34%
1%
678 678
194% 194%
14%
- Depreciation and Amortization 658 658
16% 16%
13%
EBIT (Operating Income) EBIT 20 20
102% 102%
0%
Net Profit -188 -188
90% 90%
-4%

In millions USD.

Don't miss a Thing! We will send you all news about Albemarle directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Albemarle Stock News

Neutral
The Motley Fool
4 days ago
The growing demand for lithium for energy storage is offsetting global weakness in demand from electric vehicle batteries. Management has implemented cost-cutting measures and productivity enhancements that are reducing expenses and enhancing profit potential.
Neutral
The Motley Fool
4 days ago
New markets are opening up for Albemarle's lithium products. Recent 3M spinoff Solventum is finding its footing.
Positive
Seeking Alpha
9 days ago
Albemarle is rebounding as lithium prices rise and demand remains strong, supporting a bullish investment thesis. The lithium miner has achieved positive cash flow even at low lithium prices, demonstrating operational sustainability and financial discipline. ESS demand is contributing to a boost in lithium prices, with soaring demand for stationary storage boosting an already strong EV market.
More Albemarle News

Company Profile

Albemarle Corp. is a specialty company, which engages in developing, manufacturing, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Lithium, Bromine Specialties, and Catalysts. The Lithium segment engages in developing and manufacture of basic lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties and reagents. The Bromine Specialties segment consists of bromine and bromine-based business includes products used in fire safety solutions and other specialty chemicals applications. The Catalysts segment contain two product lines: clean fuels technologies, which is primarily composed of hydro processing catalysts, and heavy oil upgrading that comprises of fluidized catalytic cracking catalysts and additives. The company was founded in 1993 and is headquartered in Charlotte, NC.

Head office United States
CEO Jerry Masters
Employees 8,300
Founded 1993
Website www.albemarle.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today